FIGURE 8.
Effects of rolipram on LV function and blood pressure. Rolipram (0.1 mg/kg, ip) was administered at the time of CLP and LV function and blood pressure were measured at 6 h. Rolipram protected against the CLP-induced decline in dP/dt max (A), the decline in dP/dt min (B), and the increase in Tau (C) without affecting mean arterial pressure (D); ∗p < 0.05 compared to 6 h Sham and 6 h CLP + Rolipram; n = 5–6 in all groups.